AL-15469A for the Treatment of Bacterial Conjunctivitis
Phase 3
Completed
- Conditions
- Bacterial Conjunctivitis
- Registration Number
- NCT00331916
- Lead Sponsor
- Alcon Research
- Brief Summary
The purpose of the study is to determine whether AL-15469A is safe and effective in the treatment of bacterial conjunctivitis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
- Signs & Symptoms of conjunctivitis
Exclusion Criteria
- Under 1 mo. age
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Clinical cure and microbiological success
- Secondary Outcome Measures
Name Time Method Individual signs and symptoms of bacterial conjunctivitis at each visit
Trial Locations
- Locations (1)
US
🇺🇸Fort Worth, Texas, United States